Deutsche Bank’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-56,188
| Closed | -$1.35M | – | 4023 |
|
|
2023
Q1 | $1.35M | Buy |
56,188
+17,532
| +45% | +$423K | ﹤0.01% | 1911 |
|
|
2022
Q4 | $409K | Buy |
38,656
+4,538
| +13% | +$48K | ﹤0.01% | 2553 |
|
|
2022
Q3 | $153K | Buy |
34,118
+5,995
| +21% | +$26.9K | ﹤0.01% | 3087 |
|
|
2022
Q2 | $113K | Sell |
28,123
-2,362
| -8% | -$9.49K | ﹤0.01% | 3447 |
|
|
2022
Q1 | $223K | Sell |
30,485
-11,759
| -28% | -$86K | ﹤0.01% | 3182 |
|
|
2021
Q4 | $237K | Sell |
42,244
-37,376
| -47% | -$210K | ﹤0.01% | 3267 |
|
|
2021
Q3 | $509K | Buy |
79,620
+32,857
| +70% | +$210K | ﹤0.01% | 3004 |
|
|
2021
Q2 | $394K | Sell |
46,763
-23,457
| -33% | -$198K | ﹤0.01% | 3360 |
|
|
2021
Q1 | $737K | Buy |
70,220
+27,304
| +64% | +$287K | ﹤0.01% | 2837 |
|
|
2020
Q4 | $727K | Buy |
42,916
+14,187
| +49% | +$240K | ﹤0.01% | 2647 |
|
|
2020
Q3 | $368K | Buy |
28,729
+4,463
| +18% | +$57.2K | ﹤0.01% | 2801 |
|
|
2020
Q2 | $342K | Buy |
+24,266
| New | +$342K | ﹤0.01% | 2810 |
|